Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pathologic Complete Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT07754812
What this trial is testing

Oral Paclitaxel Solution With Immunotherapy and Concurrent SBRT as Neoadjuvant Treatment for Older Adults With NSCLC

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)
Shanghai Pulmonary Hospital, Shanghai, China 78
Large-scale testing (Phase 3)Looking for participantsNCT06606730
What this trial is testing

Personalizing the Use of Pembrolizumab for Patients Who Have a Strong Response in Early Triple Negative Breast Cancer

Who this might be right for
Breast CancersTriple Negative Breast Cancer (TNBC)
UNICANCER 2,454
Not applicableLooking for participantsNCT06719414
What this trial is testing

Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer

Who this might be right for
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 320
Testing effectiveness (Phase 2)Study completedNCT05103293
What this trial is testing

PTC Guiding Neoadjuvant Treatment in Breast Cancer

Who this might be right for
Pathological Conditions, Signs and Symptoms
Zhejiang Cancer Hospital 86
Not applicableStudy completedNCT03601689
What this trial is testing

Predictive Factors of Disease-free Survival After Complete Pathological Response to Neoadjuvant Radiotherapy in Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Moroccan Society of Surgery 84
Not applicableUnknownNCT02907827
What this trial is testing

Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.

Who this might be right for
Melanoma
Universitair Ziekenhuis Brussel 100
Large-scale testing (Phase 3)Looking for participantsNCT06498635
What this trial is testing

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Who this might be right for
Lung Non-Small Cell CarcinomaStage II Lung Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8+1 more
National Cancer Institute (NCI) 306
Testing effectiveness (Phase 2)Study completedNCT00343720
What this trial is testing

Study of Alimta® (Pemetrexed) Plus VELCADE® (Bortezomib) or Alimta Alone or VELCADE Alone in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Prior Therapy

Who this might be right for
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Not Yet RecruitingNCT07672223
What this trial is testing

SYS6010 Plus Anti-PD-(L)-1 Monoclonal Antibody as Adjuvant Therapy in Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd. 570
Testing effectiveness (Phase 2)Active Not RecruitingNCT04722172
What this trial is testing

A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Memorial Sloan Kettering Cancer Center 55
Not applicableNot Yet RecruitingNCT07164872
What this trial is testing

Neoadjuvant Chemotherapy Combined With Preoperative Radiotherapy for Locally Advanced Breast Cancer

Who this might be right for
Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Not applicableLooking for participantsNCT06451393
What this trial is testing

Predicting Gastric Cancer Response to Chemo With Multimodal AI Model

Who this might be right for
Gastric CancerChemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University 500
Large-scale testing (Phase 3)Looking for participantsNCT06876714
What this trial is testing

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Early Stage HER2+ Breast Cancer
Alliance for Clinical Trials in Oncology 1,524
Testing effectiveness (Phase 2)UnknownNCT06154109
What this trial is testing

Comparative Efficacy of Xiaopi Granules and Decoction in Triple-negative Breast Cancer: a Randomized Controlled Trial

Who this might be right for
Triple Negative Breast Neoplasms
Zhiyu Wang 90
Testing effectiveness (Phase 2)Study completedNCT03188393
What this trial is testing

Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery

Who this might be right for
Invasive Breast CarcinomaStage II Breast CancerStage IIA Breast Cancer+2 more
NRG Oncology 105
Not applicableUnknownNCT04457700
What this trial is testing

CT-based Radiomics of ALN pCR (ypN0) in Breast Cancer Undergoing NAC

Who this might be right for
Triple-negative Breast CancerHER2-positive Breast Cancer
Peking University 218
Large-scale testing (Phase 3)Study completedNCT02613026
What this trial is testing

Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

Who this might be right for
Breast Neoplasms
307 Hospital of PLA 104
Not applicableStudy completedNCT04443985
What this trial is testing

A Cohort of Predictive Factor of Pathologic Complete Response After Preoperative Neoadjuvant in Rectum Cancer

Who this might be right for
Rectum Cancer
Mahidol University 140
Testing effectiveness (Phase 2)UnknownNCT03417427
What this trial is testing

A Clinical Trail of Demethylation Drug Combined With Chemotherapy in Intermediate-risk AML

Who this might be right for
Leukemia, Myeloid
Xuejie Jiang 100
Not applicableNot Yet RecruitingNCT07500129
What this trial is testing

Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

Who this might be right for
Breast CancerInvasive Breast CarcinomaExosomal microRNA+2 more
Atlas University 60
Next Page